Showing results (221-230 of 3,634) with videos related to

Sort By:
Pageof 364
Breast (Edinburgh, Scotland)|June 25, 2021
Clinicopathological response to neoadjuvant therapies and pathological complete response as a biomarker of survival in human epidermal growth factor receptor-2 enriched breast cancer - A retrospective cohort studyMatthew G Davey, Eoin Kerin, C O'Flaherty, et al.
Breast (Edinburgh, Scotland)|July 17, 2021
Tumour-infiltrating lymphocytes in non-invasive breast cancer: A systematic review and meta-analysisRafael Caparica, Marco Bruzzone, Elisa Agostinetto, et al.
Breast (Edinburgh, Scotland)|July 3, 2021
The cost impact of unselective vs selective MammaPrint testing in early-stage breast cancer in Southern AfricaEttienne J Myburgh, Josephus J de Jager, Elizabeth Murray, et al.
Breast (Edinburgh, Scotland)|July 4, 2021
Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterationsFabio Conforti, Laura Pala, Eleonora Pagan, et al.
Breast (Edinburgh, Scotland)|July 9, 2021
Ten years follow-up of histologically benign calcifications in the breast after vacuum-assisted stereotactic biopsy (VASB): Is additional mammographic follow-up warranted?Sara van Bekkum, Francina E M Dams, Pieter J Westenend, et al.
Breast (Edinburgh, Scotland)|June 12, 2021
Population-based mammography screening attendance in Sweden 2017-2018: A cross-sectional register study to assess the impact of sociodemographic factorsMagdalena Lagerlund, Anna Åkesson, Sophia Zackrisson
Breast (Edinburgh, Scotland)|June 14, 2021
Internal mammary node irradiation in node-positive breast cancer treated with mastectomy and taxane-based chemotherapyWon Kyung Cho, Jee Suk Chang, Seung Gyu Park, et al.
Breast (Edinburgh, Scotland)|May 15, 2022
Does receiving high or low breast cancer risk estimates produce a reduction in subsequent breast cancer screening attendance? Cohort studyDavid P French, Lorna McWilliams, Anthony Howell, et al.
Breast (Edinburgh, Scotland)|July 25, 2021
Quality of life of therapies for hormone receptor positive advanced/metastatic breast cancer: Regulatory aspects and clinical impact in EuropeL Moscetti, I Sperduti, A Frassoldati, et al.
Breast (Edinburgh, Scotland)|November 14, 2017
Treatment adoption and relative effectiveness of aromatase inhibitors compared to tamoxifen in early breast cancer: A multi-institutional observational studyArlindo R Ferreira, Ana Palha, Lurdes Correia, et al.
Pageof 364